Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 376491000036112 | benserazide 12.5 mg + levodopa 50 mg dispersible tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 376501000036117 | levodopa 50 mg + benserazide 12.5 mg dispersible tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet | Is a | levodopa + benserazide | true | Inferred relationship | Some | ||
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet | has intended active ingredient | benserazide | true | Inferred relationship | Some | 1387853162 | |
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet | has Australian BoSS | benserazide | true | Inferred relationship | Some | 1387853162 | |
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet | has intended active ingredient | levodopa | true | Inferred relationship | Some | 1205287094 | |
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet | has Australian BoSS | levodopa | true | Inferred relationship | Some | 1205287094 | |
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet | has manufactured dose form | dispersible tablet | true | Inferred relationship | Some | ||
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet | has unit of use | tablet | true | Inferred relationship | Some | 1387853163 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Madopar Rapid 62.5 dispersible tablet | Is a | True | levodopa 50 mg + benserazide 12.5 mg dispersible tablet | Inferred relationship | Some | |
| levodopa 50 mg + benserazide 12.5 mg dispersible tablet, 100 | has MPUU | True | levodopa 50 mg + benserazide 12.5 mg dispersible tablet | Inferred relationship | Some | 1 |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product unit of use reference set
FHIR